Find: Clinical Trials

6 trials sponsored by Find, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Find: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
Targeted next-generation sequencing - Drug-resistant Tuberculosis, HIV Coinfection
Not applicableRecruitingUniversity of California, San Francisco25002024-08-012026-01-26
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Ganfeborole, BTZ-043, Bedaquiline (B) - Pulmonary Tuberculosis
Phase 2RecruitingUniversity College, London25002024-01-092026-10-15
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
Digital based contact tracing - COVID-19
Not applicableCompletedElizabeth Glaser Pediatric AIDS Foundation4332022-10-182023-12-18
Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2
Rapid Antigen Testing - Severe Acute Respiratory Syndrome Coronavirus 2 Infection
CompletedElizabeth Glaser Pediatric AIDS Foundation50002022-06-202023-04-19
Point-of-care Triage Test for Active Tuberculosis
Multi-biomarker point-of-care test - Tuberculosis, Tuberculosis, Pulmonary
UnknownUniversity of Stellenbosch9002020-11-052022-01-25
Performance Evaluation of TB Breath- and Cough-testing Platforms
Rapid Biosensor Systems (RBS) TB Breathalyser, eNose AeonoseTM - Pulmonary TB, Diagnoses Diseases
UnknownFind3602017-05-292017-07-21

Conditions studied

Tuberculosis, Pulmonary (3)  ·  COVID-19 (2)  ·  HIV Infections (1)  ·  Tuberculosis (1)  ·  Tuberculosis, Multidrug-Resistant (1)

Interventions

2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (1)  ·  Ethambutol (1)  ·  Fumigant 93 (1)  ·  GSK656 (1)  ·  Isoniazid (1)  ·  Linezolid (1)  ·  Moxifloxacin (1)  ·  OPC-67683 (1)  ·  Protons (1)  ·  Pyrazinamide (1)  ·  Rifampin (1)  ·  bedaquiline (1)  ·  delpazolid (1)  ·  pretomanid (1)

Countries

South Africa (4)  ·  Cameroon (1)  ·  Kenya (1)  ·  Moldova (1)  ·  Tanzania (1)  ·  Uganda (1)  ·  Vietnam (1)

Top investigators

Boris Tchakounte Youngui, MD, MPH (1)  ·  Gerhard Walzl, MBCHB; PhD (1)  ·  Godfrey Woelk, PhD, MCOMMH (1)  ·  John Z Metcalfe, MD, PhD (1)  ·  Timothy C Rodwell, MD, PhD, MPH (1)

Results publications

PMID 37400753, PMID 39109192, PMID 39591654, PMID 40017704

NIH funding

R01AI153213 (1)